NAUTILUS BIOTECHNOLOGY INC (NAUT)

NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nautilus Biotechnology (NASDAQ:NAUT) just reported results for the first quarte...

NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q1 2024

NAUT stock results show that Nautilus Biotechnology beat analyst estimates for earnings per share the first quarter of 2024.

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome...

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein...

Top Buys by Top Brass: CEO Patel's $140.5K Bet on NAUT

Nautilus Biotechnology files $300M mixed securities shelf (NASDAQ:NAUT)

Nautilus Biotechnology files prospectus for $300M mixed securities shelf.

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome...

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein...

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

Society award recognizes Dr. Mallick’s decades of innovative leadership and science advancing the field of computational proteomics

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

Society award recognizes Dr. Mallick’s decades of innovative leadership and science advancing the field of computational proteomics...

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively quantifying the proteome

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively...

Nautilus Biotechnology GAAP EPS of -$0.13 misses by $0.01 (NASDAQ:NAUT)

Nautilus Biotechnology reports Q3 financial results, with GAAP EPS of -$0.13 missing expectations by $0.01.

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

SEATTLE, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome...

Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023

Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023

SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...

Nautilus Biotechnology to Participate in Upcoming September Investor Conferences

Nautilus Biotechnology to Participate in Upcoming August Investor Conferences

Nautilus Biotechnology to Participate in Upcoming August Investor Conferences

SEATTLE, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...

(NASDAQ:NAUT)

Nautilus Biotechnology press release (NAUT): Q2 GAAP EPS of -$0.13 beats by $0.01.Cash, cash equivalents, and investments were $286.7 million as of June 30, 2023.

Nautilus Biotechnology Reports Second Quarter 2023 Financial Results

Nautilus Biotechnology Reports Second Quarter 2023 Financial Results

SEATTLE, Wash., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule...

Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023

Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023

SEATTLE, July 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the second quarter before market open on Wednesday, August 2, 2023.